A 2007 clinical review found that ALC improved nerve function and reduced pain scores in people with peripheral neuropathy (PubMed)
Bianchi R, Cervellini I, Porretta-Serapiglia C, Oggioni N, Burkey B, Ghezzi P et al (2012) Beneficial effects of PKF275-055, a novel, selective, orally bioavailable, long-acting dipeptidyl peptidase IV inhibitor in streptozotocin-induced diabetic peripheral neuropathy
A growing body of evidence suggests that sulforaphane's protective effects extend to the brain
First, needle avoidance a meaningful fraction of patients refused injectable therapy entirely
Vendido por VITAZONE MEXICO SA DE CV $299 MXN Agregar a favoritos Compartir Producto AGOTADO
Its used off-label in functional and regenerative medicine settings